IndustryIntelligence | Biological Products

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$38	Subscribers Preview	2000	Abgenix and CuraGen to Develop Up to 250 Antibody Therapeutic Candidates	Abgenix, Inc.	CuraGen Corp.
$38	Subscribers Preview	2003	Abstract	Wiehle, Ronald Dennis	Zonagen, Inc.
$45	Subscribers Preview	2002	Access Agreement	ACLARA; Third Wave; Chase Manhattan	Latham & Watkins; WSGR
$32	Subscribers	2003	Addendum	OXiGENE, Inc.
$38	Subscribers Preview	2002	Addendum	OXiGENE, Inc.
$34	Subscribers Preview	2003	Agreement	Amgen; Tularik	Wells Fargo Bank
$44	Subscribers Preview	2004	Agreement	Antigenics, Inc.
$43	Subscribers Preview	2000	Agreement	GPH, S.A.; Genopoietic, S.A.; Jean-Loup Salzmann	David R. Klatzmann; AVAX
$48	Subscribers Preview	2001	Agreement	IDEC Pharmaceuticals Corporation; MDS Nordion Inc.	Biogen Idec
$36	Subscribers Preview	2003	Agreement	CancerVax; Regents of UC; UCLA	Fulbright; Perkins Coie
$42	Subscribers Preview	2003	Agreement	CancerVax; Regents of UC; UCLA	Fulbright; Perkins Coie
$42	Subscribers Preview	2003	Agreement	Corixa Corp.
$38	Subscribers Preview	2000	Agreement	Ontogeny Incorporated; The Board of Trustees of the Leland Stanford Junior University	Curis; Stanford
$52	Subscribers Preview	2000	Agreement	Ontogeny Inc.; The University of Washington; The Johns Hopkins University	Biogen 2 3
$41	Subscribers Preview	2004	Agreement	Amylin Pharmaceuticals Inc.	Curis, Inc.
$46	Subscribers Preview	2000	Agreement	Curis, Inc.	Stanford University
$57	Subscribers Preview	2000	Agreement	Biogen; Curis; Columbia	Harvard; Foley Hoag
$45	Subscribers Preview	2004	Agreement	CytRx Corp.	Fish & Richardson
$61	Subscribers Preview	2004	Agreement	Robert L. Hunter; CytRx; Merck	Progenics; Vical
$34	Subscribers Preview	2003	Agreement	CytRx; Ignarro, Louis	UCLA